menu search

Ionis (ions) posts encouraging data from amyloidosis drug study

Ionis (IONS) reports positive 85-week phase III study data, supporting the benefits of eplontersen as a...

July 11, 2023, 11:03 am

Totalenergies (tte), socar start production in absheron gas field

TotalEnergies (TTE) and its partner start production of the first development phase of the Absheron gas...

July 11, 2023, 9:32 am

Spc nickel reports additional drill results from west graham project

SPC Nickel Corp (TSX-V:SPC, OTC:SPCNF) has reported assay results from the last 11 drill holes from its phase ...

July 11, 2023, 8:45 am

Nanoviricides reveals promising efficacy of its antiviral drug candidate in combating rsv

NanoViricides Inc (NYSE-A:NNVC) has announced the promising efficacy of its antiviral drug candidate NV-387 in combating Respiratory Syncytial Virus ...

July 11, 2023, 8:17 am

Missed out on the ai rally? my best ai stock to buy and hold (even now)

The development of practical AI features will be key for Tesla's next phase of growth. Full self-drivin...

July 11, 2023, 5:10 am

Biolinerx: pdufa catalyst and pdac advancement make this worth a look

A PDUFA date of September 9, 2023 has been established for review of Motixafortide for Autologous Transplantation in Multiple Myeloma. Results from a ...

July 10, 2023, 7:36 pm

Allovir: 'takes one to know one'

Gilead has purchased $10.9 million in shares of Allovir, a biotech company specializing in cell therapy and organ transplant, giving it a 15% ownershi...

July 10, 2023, 7:13 pm

Microsoft stock: time to be cautious (rating downgrade)

Unfortunately, there are some signs that Microsoft stock may correct or enter a boring consolidation phase. The technology sector is losing its steam ...

July 10, 2023, 6:19 pm

Morphic: high valuation not justified by data, development status, or cash

Morphic Holding, Inc. is progressing with its trials nicely enough. I just have a problem with the nearly $3bn valuation for this ...

July 10, 2023, 3:12 pm

Nanobiotix surges on commercialization deal with j&j's janssen for cancer therapeutic

French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to licen...

July 10, 2023, 1:11 pm

Atossa therapeutics provides update on phase 2 breast density trial enrollment

Atossa Therapeutics Inc (NASDAQ:ATOS) announced that 170 patients have been enrolled across its ongoing phase ...

July 10, 2023, 10:37 am

Enphase energy is still converting solar energy into profits

Solar energy products maker Enphase NYSE: ENPH stock has fallen from grace after hitting all-time highs...

July 10, 2023, 6:50 am

Mirum: must watch biotech on release of results from embark study

Results from the phase 2b EMBARK study, which is using LIMVARLI for the treatment of patients with bili...

July 9, 2023, 11:01 am

Cassava sciences: positive data continues to derisk ongoing phase 3 trials

Cassava Sciences: Positive Data Continues To Derisk Ongoing phase 3 Trials...

July 9, 2023, 10:48 am

Sana biotechnology: hypoimmune platform might stealth cells

Results from the phase 1 study using SC291 for the treatment of patients with B-cell lymphomas are expe...

July 9, 2023, 10:09 am

General dynamics (gd) wins $257m deal for booker combat vehicle

General Dynamics' (GD) business unit clinches a $257.6-million modification contract for the second phase ...

July 7, 2023, 10:08 am

Ultragenyx (rare) doses first patients in bone disease studies

Ultragenyx (RARE) announces dosing the first patients in its phase III studies evaluating setrusumab (U...

July 7, 2023, 9:23 am

Will enphase energy (enph) beat estimates again in its next earnings report?

Enphase Energy (ENPH) has an impressive earnings surprise history and currently possesses the right com...

July 6, 2023, 1:50 pm

Here's why novocure stock dropped 42% in june

Novocure published the results of an important phase 3 clinical trial last month. The treatment clearly...

July 6, 2023, 1:17 pm

Harbor custom development finalizes loan deal with sound capital for belfair view apartment project refinancing

Harbor Custom Development said it has closed on a $19,950,000 loan with lender Sound Capital to refinance the first ...

July 6, 2023, 10:56 am


Search within

Pages Search Results: